ArticleScientific reports2026
Leveraging CT-derived chronic imaging signatures for acute kidney injury evaluation.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Accurate estimation of baseline serum creatinine (SCr) remains an unmet clinical need in acute kidney injury (AKI) evaluation, as premorbid SCr values are often unavailable. This study aimed to develop and validate a baseline SCr prediction model using CT-derived imaging features to improve AKI diagnosis and staging. The study included patients with available baseline SCr who underwent abdominal CT at two tertiary hospitals. Kidney segmentation was performed using a fine-tuned Swin UNETR model, from which imaging features were extracted. We evaluated machine learning models incorporating imaging features for baseline SCr estimation and compared their estimates with those derived from the back-calculation method. Most selected imaging features were associated with the presence of preexisting chronic kidney disease. Across internal and external test sets, the tabular foundation models achieved the best performance (MAE, 0.154-0.158/0.168-0.174; RMSE, 0.253-0.261/0.220-0.231). AKI staging based on predicted baseline SCr showed substantially higher agreement with the ground truth than back-calculation (Cohen's κ, 0.69/0.60 vs. 0.31/0.36), while markedly reducing over-staging (8.7%/8.5% vs. 45.2%/37.6%). Our externally validated, image-driven prediction model enabled accurate baseline SCr estimation and improved AKI classification.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.